Skip to main content
Top
Published in: International Urology and Nephrology 7/2014

01-07-2014 | Urology - Original Paper

Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes

Authors: Min-Shen Chung, Yao-Chi Chuang, Jong-Jer Lee, Wei-Chia Lee, Michael B. Chancellor, Rue-Tsuan Liu

Published in: International Urology and Nephrology | Issue 7/2014

Login to get access

Abstract

Objective

To evaluate the correlates of nocturia and subsequent mortality in patients with type 2 diabetes mellitus (T2DM).

Methods

A self-administered questionnaire containing overactive bladder symptom score was obtained from subjects with T2DM. Nocturia and severe nocturia were defined as rising ≥2 or ≥3 per night to void, respectively. Patient characteristics and diabetes-related complications to risk of nocturia were evaluated.

Results

Of 1,301 consecutive subjects, 59.6 and 25.3 % reported having nocturia and severe nocturia, respectively. The presence and severity of nocturia increased with age and overactive bladder (OAB). The presence of OAB was 28.8 % in patients with nocturia and was significantly associated with nocturia (OR 2.26) after adjustment for age and duration of DM. The presence of stroke, calcium channel blocker use, hypertension, waist circumference greater than standard, albuminuria, and higher serum creatinine level, and high-sensitivity C-reactive protein was associated with nocturia and severe nocturia after adjustment for age, duration of DM, and the presence of OAB. Higher estimated glomerular filtration rate, hemoglobin, serum albumin, and male gender were less likely to have nocturia (OR <1). Severe nocturia increased mortality (OR 1.93) independent of age and DM duration and has a higher mortality rate compared to those without severe nocturia (6.1 vs. 2.4 %, P = 0.001) in 2.5 years follow-up.

Conclusions

While OAB is an important predictor of nocturia in T2DM patients, systemic issues, including stroke, hypertension, obesity, and chronic kidney disease, have further impact on nocturia independent of OAB. Severe nocturia is a marker for increased mortality.
Literature
1.
go back to reference van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society. Neurourol Urodynam 21:179–183CrossRef van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the standardisation sub-committee of the international continence society. Neurourol Urodynam 21:179–183CrossRef
2.
go back to reference van Dijk L, Kooij DG, Schellevis FG (2002) Nocturia in the Dutch adult population. BJU Int 90:644–648PubMedCrossRef van Dijk L, Kooij DG, Schellevis FG (2002) Nocturia in the Dutch adult population. BJU Int 90:644–648PubMedCrossRef
3.
go back to reference Fitzgerald MP, Litman HJ, Link CL, McKinlay JB (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 177:1385–1389PubMedCrossRef Fitzgerald MP, Litman HJ, Link CL, McKinlay JB (2007) The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 177:1385–1389PubMedCrossRef
4.
go back to reference Ruud Bosch JLH, Weiss JP (2010) The prevalence and causes of nocturia. J Urol 184:440–446CrossRef Ruud Bosch JLH, Weiss JP (2010) The prevalence and causes of nocturia. J Urol 184:440–446CrossRef
5.
go back to reference Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315PubMedCrossRef Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315PubMedCrossRef
6.
go back to reference Liu RT, Chung MS, Lee WC et al (2011) Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef Liu RT, Chung MS, Lee WC et al (2011) Prevalence of overactive bladder (OAB) and associated risk factors in 1,359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef
7.
go back to reference Gulur DM, Mevcha AM, Drake MJ (2011) Nocturia as a manifestation of systemic disease. BJU Int 107:702–713PubMedCrossRef Gulur DM, Mevcha AM, Drake MJ (2011) Nocturia as a manifestation of systemic disease. BJU Int 107:702–713PubMedCrossRef
8.
go back to reference Yoshimura K (2012) Correlates for nocturia: a review of epidemiological studies. Int J Urol 19:317–329PubMedCrossRef Yoshimura K (2012) Correlates for nocturia: a review of epidemiological studies. Int J Urol 19:317–329PubMedCrossRef
9.
go back to reference Yamaguchi C, Sakakibara R, Uchiyama T et al (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodynam 26:807–813CrossRef Yamaguchi C, Sakakibara R, Uchiyama T et al (2007) Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodynam 26:807–813CrossRef
10.
go back to reference Yoshimura N, Chancellor MB, Andersson KE et al (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef Yoshimura N, Chancellor MB, Andersson KE et al (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef
11.
go back to reference Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68:318–323PubMedCrossRef Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome: overactive bladder symptom score. Urology 68:318–323PubMedCrossRef
12.
go back to reference Liew LC, Tiong HY, Wong ML et al (2006) A population study of nocturia in Singapore. BJU Int 97:109–112PubMedCrossRef Liew LC, Tiong HY, Wong ML et al (2006) A population study of nocturia in Singapore. BJU Int 97:109–112PubMedCrossRef
13.
go back to reference Tibaek S, Gard G, Klarskov P et al (2008) Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 27:763–771PubMedCrossRef Tibaek S, Gard G, Klarskov P et al (2008) Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey. Neurourol Urodyn 27:763–771PubMedCrossRef
17.
go back to reference Tai HC, Chung SD, Ho CH et al (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95:1143–1150PubMedCrossRef Tai HC, Chung SD, Ho CH et al (2010) Metabolic syndrome components worsen lower urinary tract symptoms in women with type 2 diabetes. J Clin Endocrinol Metab 95:1143–1150PubMedCrossRef
18.
go back to reference Wu MY, Wu YL, Hsu YH, Lin YF, Fan YC, Lin YC, Chang SJ (2012) Risks of nocturia in patients with chronic kidney disease- doe the metabolic syndrome and its components matter? J Urol 188:2269–2273PubMedCrossRef Wu MY, Wu YL, Hsu YH, Lin YF, Fan YC, Lin YC, Chang SJ (2012) Risks of nocturia in patients with chronic kidney disease- doe the metabolic syndrome and its components matter? J Urol 188:2269–2273PubMedCrossRef
19.
go back to reference Kupelian V, McVary KT, Barry MJ et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Bostonarea community health survey. Urology 73:950–957PubMedCentralPubMedCrossRef Kupelian V, McVary KT, Barry MJ et al (2009) Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Bostonarea community health survey. Urology 73:950–957PubMedCentralPubMedCrossRef
20.
go back to reference Lu Z, Gao Y, Tan A et al (2012) Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang Area Male Health and Examination Survey. Prostate 72:193–200PubMedCrossRef Lu Z, Gao Y, Tan A et al (2012) Increased high-sensitivity C-reactive protein predicts a high risk of lower urinary tract symptoms in Chinese male: results from the Fangchenggang Area Male Health and Examination Survey. Prostate 72:193–200PubMedCrossRef
21.
go back to reference van Doorn B, Kok ET, Blanker MH et al (2012) Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol 187:1727–1731PubMedCrossRef van Doorn B, Kok ET, Blanker MH et al (2012) Mortality in older men with nocturia. A 15-year followup of the Krimpen study. J Urol 187:1727–1731PubMedCrossRef
22.
go back to reference Kupelian V, Fitzgerald MP, Kaplan SA et al (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185:571–577PubMedCrossRef Kupelian V, Fitzgerald MP, Kaplan SA et al (2011) Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 185:571–577PubMedCrossRef
23.
go back to reference Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297–301PubMedCrossRef Asplund R (1999) Mortality in the elderly in relation to nocturnal micturition. BJU Int 84:297–301PubMedCrossRef
Metadata
Title
Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes
Authors
Min-Shen Chung
Yao-Chi Chuang
Jong-Jer Lee
Wei-Chia Lee
Michael B. Chancellor
Rue-Tsuan Liu
Publication date
01-07-2014
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 7/2014
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0669-2

Other articles of this Issue 7/2014

International Urology and Nephrology 7/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine